ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,064.20
0.91%
US Tech 100
17,178.00
1.88%
다우존스 지수
38,225.66
0.85%
Bitcoin
59,560.04
0.74%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Akero Therapeutics Inc (AKRO)

  7. Akero Therapeutics Inc (AKRO) 뉴스

AKRO Akero Therapeutics Inc

19.71
-0.37 (-1.84%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Akero Therapeutics Inc AKRO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.37 -1.84% 19.71 09:00:00
개장가 저가 고가 종가 전일 종가
20.44 19.64 20.44 19.71 20.08
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202421:00GLOBEAkero Therapeutics Appoints Scott Gangloff as Chief..
09/03/202406:02GLOBEAkero Therapeutics Announces Closing of Public Offering of..
08/03/202406:01GLOBEAkero Therapeutics Announces Publication of Phase 2b..
07/03/202410:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202410:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202407:25EDGAR2Form 8-K - Current report
07/03/202407:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/03/202411:13GLOBEAkero Therapeutics Announces Pricing of Public Offering of..
06/03/202407:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202420:05IHMARKETNEWSAMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on..
05/03/202407:34EDGAR2Form 144 - Report of proposed sale of securities
05/03/202407:30EDGAR2Form 144 - Report of proposed sale of securities
05/03/202407:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/03/202406:21GLOBEAkero Therapeutics Announces Proposed Public Offering of..
04/03/202421:55EDGAR2Form 8-K - Current report
04/03/202420:00GLOBEAkero Therapeutics Reports Statistically Significant..
01/03/202406:42EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/02/202422:00GLOBEAkero Therapeutics to Present Topline Week 96 Results from..
29/02/202421:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/02/202421:15EDGAR2Form 8-K - Current report
29/02/202421:00GLOBEAkero Therapeutics Reports Fourth Quarter and Full Year 2023..
14/02/202411:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
04/01/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202422:15GLOBEAkero Therapeutics to Present at the 42nd Annual J.P. Morgan..
30/12/202310:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202308:07EDGAR2Form 144 - Report of proposed sale of securities
19/12/202310:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202310:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202310:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202310:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202310:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202321:08EDGAR2Form 8-K - Current report
18/12/202321:00GLOBEAkero Therapeutics Announces First Patients Dosed in..
13/12/202306:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202306:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202306:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202306:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202306:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202311:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202310:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202307:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202321:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202321:15EDGAR2Form 8-K - Current report
13/11/202321:00GLOBEAkero Therapeutics Reports Third Quarter 2023 Financial..
10/11/202322:57GLOBEAkero Therapeutics to Present Late-Breaking Oral and Poster..
08/11/202321:00GLOBEAkero Therapeutics to Present at Upcoming Healthcare..
18/10/202305:05GLOBEAkero Therapeutics to Present at the H.C. Wainwright 7th..
10/10/202321:04EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
AKRO
Akero Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유